文献速递血液净化与透析慢性肾脏病

蛋白尿对血液透析患者残余肾功能的不良影响

The deleterious effect of proteinuria in residual kidney function in hemodialysis patients.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

结果显示肾病范围蛋白尿是残余肾功能加速丧失的独立预测因素,风险比2.04(95%CI 1.03-4.02,P=.04),且与β2微球蛋白升高相关。

要点

  • 肾病范围蛋白尿(≥3.5 g/24h)独立预测透析首年残余肾功能加速丧失。
  • 基线蛋白尿≥3.5 g/24h者残余肾功能丧失更早(log-rank=5.25,P=.02)。
  • 蛋白尿≥3.5 g/24h与β2微球蛋白显著升高相关,支持其预后标志物价值。

核心结论

  • 起始在线血液透析滤过时肾病范围蛋白尿是残余肾功能加速丧失(包括进展为无尿)的独立预测因素。

主要发现

  • 达到主要终点(1年时KrU<2.5 mL/min)的35例患者中62.9%有肾病范围蛋白尿,而蛋白尿<3.5 g/24h者中该比例为25.5%(P=.02)。
  • 1年时尿量降至500 mL/天以下者中73%基线蛋白尿≥3.5 g/24h。
  • 残余肾功能丧失患者中最常见的原发肾病为糖尿病肾病(43%)、血管性疾病(17%)和肾小球肾炎(17%)。
  • 肾病范围蛋白尿与残余肾功能下降风险更高相关(HR 2.04,95%CI 1.03-4.02,P=.04),调整模型后结果一致。

关键数值与推荐

  • 残余肾功能保留定义为KrU≥2.5 mL/min且尿量>500 mL/天。
  • 主要终点为1年时残余肾功能丧失,定义为KrU<2.5 mL/min。
  • 蛋白尿采用24小时尿蛋白排泄量和尿蛋白肌酐比定量。

临床怎么用

  • 对起始血液透析的肾病范围蛋白尿患者应早期识别,以制定个体化策略保护残余肾功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Residual kidney function (RKF) is a major prognostic determinant in hemodialysis (HD), strongly influencing morbidity, mortality and quality of life. Although proteinuria is a well-established marker of chronic kidney disease progression, its prognostic relevance at the initiation of HD remains uncertain. This study aimed to assess the association between baseline proteinuria and RKF decline during the first year of HD. METHODS: We performed a prospective study of incident online hemodiafiltration (online-HDF) patients with preserved RKF, defined as kidney urea clearance (KrU) ≥2.5 mL/min and urine output >500 mL/day. The primary endpoint was RKF loss at 1 year, defined as KrU <2.5 mL/min. Secondary endpoints included changes in creatinine clearance (KrCr), glomerular filtration rate and 24-h urine volume. Proteinuria was quantified using both 24-h urinary protein excretion and the urine protein-to-creatinine ratio. RESULTS: Ninety-seven patients were included; 74.2% were male, with a mean age of 64.3 ± 15 years. Among the 35 patients who reached the primary outcome, 62.9% had nephrotic-range proteinuria, compared with 25.5% with proteinuria <3.5 g/24 h (P = .02). Of those whose urine output fell below 500 mL/day at 1 year, 73% had baseline proteinuria ≥3.5 g/24 h. The most frequent underlying nephropathies among patients with RKF loss were diabetic kidney disease (43%), vascular disease (17%) and glomerulonephritis (17%). Patients with proteinuria ≥3.5 g/24 h reached RKF loss significantly earlier (log-rank = 5.25; P = .02). Nephrotic-range proteinuria was associated with a higher risk of RKF decline (hazard ratio 2.04; 95% confidence interval 1.03-4.02; P = .04), a finding that remained consistent across adjusted models. β2-microglobulin levels were also significantly higher in this group. CONCLUSIONS: Nephrotic-range proteinuria at online-HDF initiation is an independent predictor of accelerated RKF loss, including progression to anuria. Its association with elevated β2-microglobulin supports its value as a prognostic marker. Early identification of high-proteinuria patients may enable personalized strategies to preserve RKF and improve outcomes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Alamo BS, Minguez I, Domínguez MED, et al. The deleterious effect of proteinuria in residual kidney function in hemodialysis patients. Nephrol Dial Transplant. 2026. PMID: 41823300. doi:10.1093/ndt/gfag058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。